BOUTIQUE精品展示
持續(xù)近兩個(gè)多月的新型冠狀病毒感染的肺炎疫情牽動(dòng)著每一個(gè)人的心，為了打贏這場疫情防控狙擊戰(zhàn)，搞清致病機(jī)理，研發(fā)抗病毒藥物和疫苗刻不容緩。Jena bioscience品牌有豐富的抗病毒核苷酸/核苷酸類似物，助力抗病毒藥物研發(fā)。
抗病毒核苷及核苷酸類似物主要有:
抗病毒核苷/核苷酸類似物可以通過抑制病毒復(fù)制的幾個(gè)關(guān)鍵過程來抑制病毒繁殖，它們通過與天然的dNTP/NTP競爭結(jié)合到新的病毒核酸中，從而導(dǎo)致鏈終止或者誘變。在細(xì)胞培養(yǎng)實(shí)驗(yàn)中，可以用抗病毒核苷酸的非磷酸化核苷變體，這種核苷酸在細(xì)胞內(nèi)被多種病毒和/或宿主激酶激活，從而發(fā)揮(tri)磷酸化形式的抗病毒作用。
熱銷抗病毒核苷/核苷酸類似物：
|
品牌 |
貨號(hào) |
品名 |
規(guī)格 |
|
Jena Bioscience |
NU-1605S |
3TCMP |
10 μl (10 mM) |
|
Jena Bioscience |
NU-1605L |
3TCMP |
5 x 10 μl (10 mM) |
|
Jena Bioscience |
NU-1606S |
3TCTP |
5 μl (10 mM) |
|
Jena Bioscience |
NU-1606L |
3TCTP |
5 x 5 μl (10 mM) |
|
Jena Bioscience |
NU-1603S |
d4TMP |
20 μl (10 mM) |
|
Jena Bioscience |
NU-1603L |
d4TMP |
5 x 20 μl (10 mM) |
|
Jena Bioscience |
NU-1601S |
AzTMP |
20 μl (10 mM) |
|
Jena Bioscience |
NU-1601L |
AzTMP |
5 x 20 μl (10 mM) |
|
Jena Bioscience |
NU-989S |
AzTTP |
10 μl (100 mM) |
|
Jena Bioscience |
NU-989L |
AzTTP |
5 x 10 μl (100 mM) |
|
Jena Bioscience |
NU-875 |
ara-Adenosine-5'-monophosphate (ara-AMP) |
2 mg |
|
Jena Bioscience |
NU-1111S |
50 μl (10 mM) |
|
|
Jena Bioscience |
NU-1111L |
ara-Adenosine-5'-triphosphate (ara-ATP) |
5 x 50 μl (10 mM) |
|
Jena Bioscience |
NU-876 |
Acyclovir-5'-monophosphate |
2 mg |
|
Jena Bioscience |
NU-877 |
Acyclovir-5'-triphosphate |
2 mg |
|
Jena Bioscience |
NU-021-2 |
Ribavirin-5'-monophosphate |
2 mg |
|
Jena Bioscience |
NU-1105S |
20 μl (10 mM) |
|
|
Jena Bioscience |
NU-1105L |
Ribavirin-triphosphate |
5 x 20 μl (10 mM) |
|
Jena Bioscience |
N-DN-8234-100 |
β-L-2'-Deoxythymidine |
100 mg |
|
Jena Bioscience |
NU-896S |
10 μl (100 mM) |
|
|
Jena Bioscience |
NU-896L |
6-Aza-UTP |
5 x 10 μl (100 mM) |
|
Jena Bioscience |
NU-974 |
Tenofovir |
100 mg |
|
Jena Bioscience |
NU-975 |
Tenofovir-diphosphate |
1 mg |
|
Jena Bioscience |
NU-989S |
10 μl (100 mM) |
|
|
Jena Bioscience |
NU-989L |
AzTTP |
5 x 10 μl (100 mM) |
|
Jena Bioscience |
NU-275S |
10 μl |
|
|
Jena Bioscience |
NU-275L |
Ganciclovir-triphosphate |
5 x 10 μl |
西美杰是Jena bioscience中國總代理，為用戶提供完善的技術(shù)與售后服務(wù)。如對產(chǎn)品感興趣歡迎撥打西美杰客服熱線400-050-4006了解詳細(xì)信息。西美杰會(huì)更好的協(xié)助科研工作者的實(shí)驗(yàn)工作，支持全國戰(zhàn)“疫”，早日戰(zhàn)勝病毒。武漢加油！中國加油！
參考文獻(xiàn)：
1] Huang at al. (2011) Effect of reverse transcriptase inhibitors on Line-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition. BMC Biochemistry 12:18.
[2] Vaccaro at al. (1999) Mechanism of Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase by d4TTP: an Equivalent Incorporation Efficiency Relative to the Natural Substrate dTTP. Antimicrob. Agents Chemother. 44 (1):217.
[3] Jaju at al. (1995) Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer. J. Biol. Chem. 270 (17):9740.
[4] Furmann at al. (1979) Inhibition of Herpes Simplex Virus-Induced DNA Polymerase Activity and Viral DNA Replication by 9-(2-Hydroxyethoxymethyl)guanine and Its Triphosphate. J. Virol. 29 (2):154.
[5] Muller at al. (1977) Inhibition of Herpesvirus DNA synthesis by 9-O-D-Arabinofuranosyladenine in cellular and cell-free systems. Ann. N.Y. Acad. Sci. 284:34.
[6] Crotty at al. (2000) The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Medicine 6 (12):1375.
[7] Ray at al. (2009) Metabolism of antiviral nucleosides and nucleotides. In: Antiviral Research: Strategies in antiviral drug discovery (LaFemina). ASM Press.
[8] Simons at al. (2005) Recent Advances in Antiviral Nucleoside and Nucleotide Therapeutics. Current Topics in Medicinal Chemistry 5:1191.
.png)
京公網(wǎng)安備 11010802028692號(hào) 
北京客服1